← Master Registry

Published peptide research references

Semax

Governed registry record

25 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Open the peptide evidence profile →

Approved source records

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

    Omar F Rahman; Steven J Lee; William A Seeds · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026

    DOI: 10.4155/fdd-2022-0009PMID: 41490200

  2. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.

    Volodymyr Mavrych; Inna Shypilova; Olena Bolgova · Frontiers in aging · 2026

    DOI: 10.1038/s41392-022-00904-4PMID: 42021992

  3. Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage.

    Ivan B Filippenkov; Yana Yu Shpetko; Daria A Ales; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Natalia K Fomina; Leonid V Gubsky; Lyudmila A Andreeva; Nikolay F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova · International journal of molecular sciences · 2025

    DOI: 10.1101/gr.1239303PMID: 40650034

  4. Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.

    Rongjie Liu; Yituo Chen; Haosheng Huang; Xiang Li; Junlei Lv; Liting Jiang; Hongyi Jiang; Chenyu Wu; Weikai Chen; Hongwei Xu; Zhefan Zhu; Haoxu Cai · British journal of pharmacology · 2025

    DOI: 10.1111/bph.70122PMID: 40692165

  5. The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.

    A I Radchenko; E V Kuzubova; A A Apostol; V A Mitkevich; L A Andreeva; S A Limborska; Yu V Stepenko; V S Shmigerova; A V Solin; M V Korokin; M V Pokrovskii; N F Myasoedov · Acta naturae · 2025

    DOI: 10.32607/actanaturae.27808PMID: 41479572

  6. ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke.

    Ivan B Filippenkov; Yana Yu Shpetko; Vasily V Stavchansky; Alina E Denisova; Leonid V Gubsky; Lyudmila A Andreeva; Nikolay F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova · Biomedicines · 2024

    DOI: 10.1038/s41598-022-20623-8PMID: 39767736

  7. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.

    Olga Yu Sudarkina; Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Liya V Valieva; Julia A Remizova; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska · International journal of molecular sciences · 2021

    DOI: 10.32388/uq8dyzPMID: 34201112

  8. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.

    Nataliya Yu Glazova; Daria M Manchenko; Maria A Volodina; Svetlana A Merchieva; Ludmila A Andreeva; Vladimir S Kudrin; Nikolai F Myasoedov; Natalia G Levitskaya · Neuropeptides · 2021

    DOI: 10.1016/j.npep.2020.102114PMID: 33418449

  9. The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.

    Yasenyavskaya A Leonidovna; Samotrueva M Aleksandrovna; Tsibizova A Aleksandrovna; Bashkina O Aleksandrovna; Myasoedov N Fedorovich; Andreeva L Aleksandrovna · Current reviews in clinical and experimental pharmacology · 2021

    DOI: 10.2174/1574884715666200704152810PMID: 32621722

  10. [The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain].

    L V Dergunova; V G Dmitrieva; I B Filippenkov; V V Stavchansky; A E Denisova; V V Yuzhakov; L E Sevan'kaeva; L V Valieva; O Y Sudarkina; L V Gubsky; N F Myasoedov; S A Limborska · Molekuliarnaia biologiia · 2021

    DOI: 10.31857/S0026898421010043PMID: 34097675

  11. Correction of Lipid Metabolism Disorders in Diabetes Mellitus with Peptide Drugs.

    A A Elagina; Yu D Lyashev; A Yu Lyashev; T V Pronyaeva; A R Chahine · Bulletin of experimental biology and medicine · 2020

    DOI: 10.1007/s10517-020-04764-2PMID: 32246363

  12. Functional Connectomic Approach to Studying Selank and Semax Effects.

    Ya R Panikratova; I S Lebedeva; O Yu Sokolov; A D Rumshiskaya; D A Kupriyanov; N V Kost; N F Myasoedov · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020

    DOI: 10.1134/S001249662001007XPMID: 32342318

  13. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.

    Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Olga Y Sudarkina; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova · Genes · 2020

    DOI: 10.1126/scitranslmed.aaf8732PMID: 32580520

  14. Pharmacological Aspects of Neuro-Immune Interactions.

    Vadim V Tarasov; Nikita V Kudryashov; Vladimir N Chubarev; Tatiana S Kalinina; George E Barreto; Ghulam Md Ashraf; Gjumrakch Aliev · Current pharmaceutical design · 2018

    DOI: 10.2174/1381612823666170829135115PMID: 28875850

  15. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke].

    E I Gusev; M Yu Martynov; E V Kostenko; L V Petrova; S N Bobyreva · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018

    DOI: 10.17116/jnevro20181183261-68PMID: 29798983

  16. Influence of ACTG4-7-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress.

    A V Ivanov; I I Bobyntsev; O M Shepeleva; A A Kryukov; L A Andreeva; N F Myasoedov · Bulletin of experimental biology and medicine · 2017

    DOI: 10.1007/s10517-017-3748-4PMID: 28577097

  17. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.

    Ekaterina V Medvedeva; Veronika G Dmitrieva; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova · Molecular genetics and genomics : MGG · 2017

    DOI: 10.1007/s00438-017-1297-1PMID: 28255762

  18. [A comparative chemoreactome analysis of mexidol].

    I Yu Torshin; O A Gromova; I S Sardaryan; L E Fedotova · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2017

    DOI: 10.17116/jnevro20171171275-84PMID: 28514338

  19. [POSSIBLE ROLE OF TRANSTHYRETIN IN THE BIOLOGICAL MECHANISM OF THE REGULATORY PEPTIDE NEUROPROTECTION.].

    T V Vyunova; E V Medvedeva; L A Andreeva; L V Dergunova; S A Limborska; N F Myasoedov · Molekuliarnaia genetika, mikrobiologiia i virusologiia · 2016

    PMID: 30383932

  20. Sigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials.

    Scott L Charland; Eric J Stanek · Pharmacotherapy · 2014

    DOI: 10.1002/phar.1368PMID: 24877185

  21. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.

    Ekaterina V Medvedeva; Veronika G Dmitrieva; Oksana V Povarova; Svetlana A Limborska; Veronika I Skvortsova; Nikolay F Myasoedov; Lyudmila V Dergunova · BMC genomics · 2014

    DOI: 10.1161/01.STR.12.6.723PMID: 24661604

  22. Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain.

    Ekaterina V Medvedeva; Veronika G Dmitrieva; Oksana V Povarova; Svetlana A Limborska; Veronika I Skvortsova; Nikolay F Myasoedov; Lyudmila V Dergunova · Journal of molecular neuroscience : MN · 2013

    DOI: 10.1007/s12031-012-9853-yPMID: 22772900

  23. [Nootropic and analgesic effects of Semax following different routes of administration].

    D M Manchenko; N Iu Glazova; N G Levitskaia; L A Andreeva; A A Kamenskiĭ; N F Miasoedov · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2010

    PMID: 21268834

  24. [Evolution of the stress concept].

    K V Sudakov · Vestnik Rossiiskoi akademii meditsinskikh nauk · 2008

    PMID: 19140465

  25. [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].

    L A Liapina; V E Pastorova; T Iu Obergan; G E Samonina; I P Ashmarin; N F Miasoedov · Izvestiia Akademii nauk. Seriia biologicheskaia · 2006

    PMID: 16634437